Kanserli hastalarda kan D-dimer değerlerinin pulmoner emboli tanısını öngörmedeki önemi (original) (raw)

2020, Journal of Health Sciences and Medicine

Aim: Cancer patients have increased risk of thrombosis. However, the use of D-dimer as a biomarker in malignancies, major surgery, infections and pregnancy was not recommended since D-dimer values were detected in high levels without PE. In this study, we aimed to evaluate the D-dimer values for the selected group of patients in the light of their clinical and demographic data and to reveal the utility of blood D-dimer measurements in cancer patients as a clinical decision rule. Also we aimed to define a new cut- off value for cancer patients who accurately diagnosed as pulmonary embolism.Material and Method: This single -center retrospective and cross-sectional study was based upon patients’ medical reports. The D-dimer values above 500 mcg/dl (>500 mcg/dl ) were considered as positive results.Results: One hundred twenty-eight patients (44 cancer patients (the case), 84 without cancer history (the control)) with accurate diagnosis of pulmonary embolism were included in the study...

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact